Keyphrases
Tumor
69%
Subclonal
39%
Tumor Cells
39%
Copy number
39%
Driver Events
39%
Cancer Evolution
38%
Reduced Expression
37%
Glioblastoma
35%
Cancer Types
35%
MicroRNA
31%
MicroRNA Signature
31%
PC12 Cells
31%
Isocitrate Dehydrogenase 1 (IDH1)
31%
Cancer Drugs
31%
Homologous Recombination Deficiency
31%
Mitochondrial mutations
31%
Aggression
31%
Hydrogen Peroxide
31%
Mesenchymal Tumor
31%
Prognostic Implications
31%
Mutational Processes
31%
Metastatic Potential
31%
Colorectal Cancer
31%
Macroevolution
31%
Platinum-based Chemotherapy
31%
ROCK Inhibitor
31%
Pan-cancer Analysis
31%
Tissue of Origin
31%
Tumor Specimens
31%
Caspase-2
31%
Cytotoxicity
31%
Somatic mutation
31%
Adaptation
31%
Clinical Trajectory
31%
Prostate Cancer
31%
Tumor Sequencing
31%
In Cancer
31%
VHL Syndrome
31%
Allele-specific Copy number
31%
Mesothelioma
26%
ERK2
23%
Primary Tumor
23%
Ebselen
23%
Platelet-derived Growth Factor Receptor (PDGFR)
23%
Compound A
23%
Compound B
23%
PARP Inhibitor (PARPi)
23%
Homologous Recombination Deficiency Score
21%
Genomic Scars
21%
Mutational Profile
21%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Homologous Recombination
63%
IDH1
63%
Pan-cancer
47%
Oncogene
42%
Single-Nucleotide Polymorphism
41%
Somatic Mutation
38%
SNP Array
38%
MicroRNA
31%
Point Mutation
31%
Phosphoinositide 3-Kinase
31%
Transcriptome
31%
Molecular Evolution
31%
Tissue Microarray
31%
Aneuploidy
31%
Whole Genome Sequencing
31%
Caspase 2
31%
Allele
31%
Germ Cell
31%
Germline
31%
Next Generation Sequencing
31%
Methylome
31%
Mitochondrial Genome
31%
Exome
25%
Platelet Derived Growth Factor Receptor Alpha
23%
mTOR Signaling
23%
Mammalian Target of Rapamycin
23%
Loss of Heterozygosity
22%
Chromosome Instability
22%
Exome Sequencing
20%
DNA Repair
19%
Poly ADP Ribose Polymerase
19%
Ploidy
19%
Mitogen-Activated Protein Kinase Kinase
15%
Mutagenesis
15%
KRAS
15%
Evolution
15%
Epidermal Growth Factor Receptor
15%
Cancer Incidence
15%
Population Research
15%
Mechanistic Target of Rapamycin
15%
